Skip Navigation
AHRQ--Agency for Healthcare Research and Quality: Advancing Excellence in Health Care
  • Home
  • Search for Research Summaries, Reviews, and Reports
 
 

EHC Component

  • EPC Project

Topic Title

  • Future Research Needs for First- and Second- Generation Antipsychotics for Children and Young Adults

Future Research Needs Projects

Future Research Needs - Methods Research Series



Research Review - Final – Feb. 20, 2012

Future Research Needs for First- and Second- Generation Antipsychotics for Children and Young Adults

Formats

People using assistive technology may not be able to fully access information in these files. For additional assistance, please contact us.

Excerpt

This future research needs (FRN) report is based on an Agency for Healthcare Research and Quality (AHRQ) comparative effectiveness review (CER) titled "First- and Second-Generation Antipsychotics for Children and Young Adults." The purpose of the CER was to review and synthesize the evidence regarding the benefits and harms of first- and second-generation antipsychotics (FGAs and SGAs) for the treatment of various psychiatric and behavioral conditions in individuals 24 years of age or younger.